NCT00520273View on ClinicalTrials.gov

A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA

NACompletedINTERVENTIONAL
Enrollment

100,000

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Healthy Volunteer
Interventions
DEVICE

cobas s 201 TaqScreen MPX Test

Donors testing reactive for one or more of the viral markers will be advised to seek further advice/treatment from their physician.

Trial Locations (3)

27619

Raleigh

FL 33487

Boca Raton

TN 38134

Memphis

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00520273 - A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA | Biotech Hunter | Biotech Hunter